Statins may contribute to interstitial lung disease. - GreenMedInfo Summary
Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.
Med J Aust. 2007 Jan 15 ;186(2):91-4. PMID: 17223772
Geelong Hospital, Geelong, Victoria, Australia. email@example.com
Over a 3-year period, seven patients who were taking HMG-CoA reductase inhibitors (statins) presented to our respiratory service with interstitial pneumonitis. Clinical course varied, with the condition responding to prednisolone treatment and cessation of statins in three patients, and progressing slowly despite this management in another three, while one patient died of associated cardiac disease. While a causative role cannot be confirmed, clinicians should be aware of the possible association.